| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.052 | 0.2 |